|
Enzo Biochem Inc. (NYSE:ENZ) announced today that they have favorable results of the Company’s clinical trial for the treatment of non-alcoholic steatohepatitis. The information was presented by Enzo Biochem at the annual meeting of the American Association for the Study of Liver Diseases. http://www.favstocks.com/enzo-biochem-na...
Currently, the causes of NASH are not well-defined due to which there is currently no medical therapy available in the market to combat NASH. Rating :
 (No ratings) |
24/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
treatment of non-alcoholic steatohepatitis.
|
sarun82@roc... | Not rated | 4-Nov-09 07:44 am | ||
|
Give me a break. Is this what you do all day long....
|
lymezhome |
 
|
4-Nov-09 09:26 pm |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.01